Showing results (1-10 of 611) with videos related to
Sort By:
Pageof 62
Experimental Neurology|October 26, 2010
Recent advances in the development of immunotherapies for tauopathiesKiren Ubhi, Eliezer MasliahJournal of Alzheimer'S Disease : JAD|July 20, 2012
Alzheimer's disease: recent advances and future perspectivesKiren Ubhi, Eliezer MasliahTrends in Neurosciences|October 4, 2011
Multiple system atrophy: a clinical and neuropathological perspectiveKiren Ubhi, Phillip Low, Eliezer MasliahGlia|December 7, 2013
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyElvira Valera, Kiren Ubhi, Michael Mante, et al.Synapse (New York, N.Y.)|October 15, 2013
Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the ratRubén Antonio Vázquez-Roque, Kiren Ubhi, Eliezer Masliah, et al.The FEBS Journal|April 17, 2009
Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's diseaseGideon M Shaked, Stephanie Chauv, Kiren Ubhi, et al.Brain Pathology (Zurich, Switzerland)|December 14, 2011
Autophagy in dementiasChristine Lund Kragh, Kiren Ubhi, Tony Wyss-Coray, et al.Neuroreport|February 9, 2012
Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophyEdward Rockenstein, Kiren Ubhi, Chandra Inglis, et al.Neuroreport|March 13, 2010
Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophyKiren Ubhi, Edward Rockenstein, Michael Mante, et al.Journal of Alzheimer'S Disease : JAD|March 16, 2011
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's diseaseDaniel Havas, Birgit Hutter-Paier, Kiren Ubhi, et al.Pageof 62